Stock indexes in Western Europe continue to rise after rising the previous day on optimism about the measures of central banks of the world and the strong statements of a number of large companies.

European shares rose yesterday and today continue to demonstrate strenght after the Bank of England lower its key interest rate to a new historic low of 0.25% and to extend the program for the purchase of government bonds by 60 billion pounds. Also, BoE announced plans to provide commercial banks of the country up to 100 billion pounds of soft loans.

The head of the Bank of England Governor Mark Carney, as previously President of the European Central Bank Mario Draghi pledged to do everything necessary to support economies experiencing a negative impact due to the British decision to withdraw from the EU structure.

The composite index of Europe's largest enterprises Stoxx 600 increased by 0.3% - up to 338.7652 points.

Shares of German Evonik Industries rose 3.9% as its profit in the 2nd quarter fell weaker than forecasts.

Price of LafargeHolcim cement producer jumped by 5.3% thanks to a strong financial performance for the last quarter.

The capitalization of the German manufacturer Hugo Boss rose by 6.6%, despite the worsening profit outlook for the current year. Revenue decreased in the last quarter, but turned out to be better than the average market forecast.

Meanwhile, Europe's biggest insurer Allianz SE has cut its net profit in the 2nd quarter almost in half due to the growth of payments to cover damage caused by natural disasters. Quotes decreased by 4.2%.

The market value of the British bank Royal Bank of Scotland fell by 4%, as its loss in the last quarter turned out to be more than analysts' expectations.

Shares of pharmaceutical company Novo Nordisk fell 6.6% after the largest producer of insulin in the world worsened the forecasts for the current year, noting the increased competition in the US, as negative impact on medicine prices.

Stocksof Hikma Pharmaceuticals PLC jumped 3% after reports that revenue from generic drugs in the first half of the year fell more than previously expected, due to some new products slow approval process.

At the moment:

FTSE 6757.99 17.83 0.26%

DAX 10241.91 14.05 0.14%

CAC 4366.22 20.59 0.47%